Reuse our editable social media cards to spread the word on vaccines for European Immunization Week 2023!

To decrease the impact of COVID-19, and related hospitalisations and mortality, countries should plan for a continued roll-out of COVID vaccines in 2023.

This document offers an overview of the available scientific evidence and epidemiological situation and provides public health considerations to support discussions and decisions on the

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 March – 1 April 2023 and includes updates on Iatrogenic botulism

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism,

This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon

ECDC has published an updated guidance on designing and conducting after-action reviews (AARs) of the public health response to the COVID-19 pandemic.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 March 2023 and includes updates on COVID-19, iatrogenic botulism, group A

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection,

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 February – 5 March 2023 and includes updates on COVID-19, group

As of 3 March 2023, ECDC will de-escalate BA.2, BA.4 and BA.5 from its list of SARS-CoV-2 variants of concern (VOC), as these parental lineages

The epidemiological situation of SARS-CoV-2 in humans and animals is continually evolving. To date, animal species known to transmit SARS-CoV-2 are American mink, raccoon dog,